Skip to main content
. Author manuscript; available in PMC: 2019 Mar 12.
Published in final edited form as: Ann Allergy Asthma Immunol. 2018 Jun 14;121(4):444–450.e1. doi: 10.1016/j.anai.2018.06.001

Table 3.

Association analyses of outcomes in patients with asthma participating in the VIDA trial stratified by groups of free vitamin D3 concentrations 12 weeks (visit 6) following the beginning of supplementation.

TREATMENT OUTCOMES VITAMIN D3 Cf, pg/ml (number of participants) p value
<9 (65) 9 – 12 (84) >12 (48)
Overall treatment failure rate/person-yr 0.60 0.53 0.69 0.51
Overall exacerbation rate/person-yr 0.28 0.15 0.42 0.22